T
TALMedora Editorial
GLP-1 Drugs May Benefit Heart Failure Patients Obesity…
GLP-1 Drugs May Benefit Heart Failure Patients Obesity Medications Show Unexpected Cardiovascular Benefits Beyond Weight Loss Obesity medications like Ozempic and Wegovy may provide significant benefits for heart failure patients beyond weight loss, according to a meta-analysis of over 43,000 adults published May 18, 2026. Researchers found GLP-1 drugs improved heart function, reduced hospitalizations, and lowered cardiovascular death risk in patients with heart failure, even in those who did not lose substantial weight. This suggest
Create an account to read the full story.
Join TALMedora to get full access
Already have an account?
Comments (0)
No comments yet. Be the first to comment!